Integrating gene expression biomarker predictions into networks of adverse outcome pathways

Yauk, 2019, The value of genomics data for regulatory decision making – a summary of case studies from Health Canada, CurrOpin Toxicol Waters, 2010, Characterizing and predicting carcinogenicity and mode of action using conventional and toxicogenomics methods, Mutat Res, 705, 184, 10.1016/j.mrrev.2010.04.005 Thomas, 2007, A method to integrate benchmark dose estimates with genomic data to assess the functional effects of chemical exposure, Toxicol Sci, 98, 240, 10.1093/toxsci/kfm092 Phillips, 2019, BMDExpress 2: enhanced transcriptomic dose-response analysis workflow, Bioinformatics, 35, 1780, 10.1093/bioinformatics/bty878 Merrick, 2019, Next generation sequencing data for use in risk assessment, Curr Opin Toxicol, 18, 18, 10.1016/j.cotox.2019.02.010 Bush, 2017, PLATE-Seq for genome-wide regulatory network analysis of high-throughput screens, Nat Commun, 8, 105, 10.1038/s41467-017-00136-z Ye, 2018, DRUG-seq for miniaturized high-throughput transcriptome profiling in drug discovery, Nat Commun, 9, 4307, 10.1038/s41467-018-06500-x Yeakley, 2017, A trichostatin A expression signature identified by TempO-Seq targeted whole transcriptome profiling, PLoS One, 12, e0178302, 10.1371/journal.pone.0178302 Shah, 2018, Predicting chemical mechanisms of action using high-throughput transcriptomic data, Toxicologist, 162, 1689 Schena, 1995, Quantitative monitoring of gene expression patterns with a complementary DNA microarray, Science, 270, 467, 10.1126/science.270.5235.467 2001, Biomarkers and surrogate endpoints: preferred definitions and conceptual framework, Clin Pharmacol Ther, 69, 89, 10.1067/mcp.2001.113989 Moreau, 2012, Computational tools for prioritizing candidate genes: boosting disease gene discovery, Nat Rev Genet, 13, 523, 10.1038/nrg3253 Corton, 2018, 1690 Ryan, 2016, Moving toward integrating gene expression profiling into high-throughput testing: a gene expression biomarker accurately predicts estrogen receptor alpha modulation in a microarray compendium, Toxicol Sci, 151, 88, 10.1093/toxsci/kfw026 Rooney, 2018, Identification of androgen receptor modulators in a prostate cancer cell line microarray compendium, Toxicol Sci, 10.1093/toxsci/kfy187 Corton, 2019, Identification of potential endocrine disrupting chemicals using gene expression biomarkers, Toxicol Appl Pharmacol, 380, 114683, 10.1016/j.taap.2019.114683 Oshida, 2015, Identification of chemical modulators of the constitutive activated receptor (CAR) in a gene expression compendium, Nucl Recept Signal, 13, 10.1621/nrs.13002 Oshida, 2015, Screening a mouse liver gene expression compendium identifies modulators of the aryl hydrocarbon receptor (AhR), Toxicology, 336, 99, 10.1016/j.tox.2015.07.005 Oshida, 2015, Identification of modulators of the nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha) in a mouse liver gene expression compendium, PLoS One, 10, 10.1371/journal.pone.0112655 Oshida, 2016, Disruption of STAT5b-regulated sexual dimorphism of the liver transcriptome by diverse factors is a common event, PLoS One, 11, 10.1371/journal.pone.0148308 Oshida, 2016, Chemical and hormonal effects on STAT5b-dependent sexual dimorphism of the liver transcriptome, PLoS One, 11 Rooney, 2018, Activation of Nrf2 in the liver is associated with stress resistance mediated by suppression of the growth hormone-regulated STAT5b transcription factor, PLoS One, 13, 10.1371/journal.pone.0200004 Kupershmidt, 2010, Ontology-based meta-analysis of global collections of high-throughput public data, PLoS One, 5, 10.1371/journal.pone.0013066 Lamb, 2007, The Connectivity Map: a new tool for biomedical research, Nat Rev Canc, 7, 54, 10.1038/nrc2044 Lamb, 2006, The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease, Science, 313, 1929, 10.1126/science.1132939 Corton, 2018, Using a gene expression biomarker to identify DNA damage-inducing agents in microarray profiles, Environ Mol Mutagen, 59, 772, 10.1002/em.22243 Peffer, 2018, Sedaxane-use of nuclear receptor transactivation assays, toxicogenomics, and toxicokinetics as part of a mode of action framework for rodent liver tumors, Toxicol Sci, 162, 582, 10.1093/toxsci/kfx281 Rooney, 2017, From the cover: genomic effects of androstenedione and sex-specific liver cancer susceptibility in mice, Toxicol Sci, 160, 15, 10.1093/toxsci/kfx153 Rooney, 2019, Chemical activation of the constitutive androstane receptor leads to activation of oxidant-induced Nrf2, Toxicol Sci, 167, 172, 10.1093/toxsci/kfy231 Boobis, 2006, IPCS framework for analyzing the relevance of a cancer mode of action for humans, Crit Rev Toxicol, 36, 781, 10.1080/10408440600977677 Ankley, 2010, Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment, Environ Toxicol Chem, 29, 730, 10.1002/etc.34 Edwards, 2016, Adverse outcome pathways-organizing toxicological information to improve decision making, J Pharmacol Exp Ther, 356, 170, 10.1124/jpet.115.228239 Vinken, 2019, Application of adverse outcome pathway framework for regulatory decision making, Curr Opin Toxicol Cohen, 2010, Evaluation of possible carcinogenic risk to humans based on liver tumors in rodent assays: the two-year bioassay is no longer necessary, Toxicol Pathol, 38, 487, 10.1177/0192623310363813 Rooney, 2018, Adverse outcome pathway-driven identification of rat liver tumorigens in short-term assays, Toxicol Appl Pharmacol, 356, 99, 10.1016/j.taap.2018.07.023 Igarashi, 2015, Open TG-GATEs a large-scale toxicogenomics database, Nucleic Acids Res, 43, D921, 10.1093/nar/gku955 Slikker, 2018, Emerging technologies for food and drug safety, Regul Toxicol Pharmacol, 98, 115, 10.1016/j.yrtph.2018.07.013 Rooney, 2019, A gene expression biomarker identifies factors that modulate sterol regulatory element binding protein, Comput Toxicol, 10.1016/j.comtox.2018.12.007 Corton, 2018, Using a gene expression biomarker to identify DNA damage-inducing agents in microarray profiles, Environ Mol Mutagen, 59, 772, 10.1002/em.22243 Rooney, 2018, Adverse outcome pathway-driven identification of rat liver tumorigens in short- term assays, Toxicol Appl Pharmacol, 356, 99, 10.1016/j.taap.2018.07.023 Corton, 2019, Frequent modulation of the sterol regulatory element binding protein (SREBP) by chemical exposure in the liver of rats, Comput Toxicol, 10, 113, 10.1016/j.comtox.2019.01.007